BONESUPPORT commenced trading on Nasdaq Stockholm following completion of its IPO, for which the final price was set at SEK 29/share (~US $3.31/share). Final proceeds after issue costs will be SEK 461MM (~$53.0MM).

BONESUPPORT markets CERAMENT injectable, drug-eluting bioceramic bone graft substitutes to treat bone voids. Funds will...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us